Tolmetin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D8K2JPN18B, chemically known as 1h-pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)- but generally known as tolmetin, which bears US NIH Compound Identifier 5509. European Medicines Agency schedules Tolmetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11162MIG. The term TOLMETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules tolmetin in its Anatomical Therapeutic Chemical (ATC) Classification. TOLMETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolmetin under HS 29339990 and SITC 51577. As of Q4 2014, TOLMETIN remains the US FDA Preferred Term for this commodity. Tolmetin bears US NLM identifiers UMLS ID C0040377 and NCI Concept Code C29503. SMILES: O=C(C1N(C(CC1)CC(=O)O)C)C1CCC(CC1)C.